Article
Accuracy of the urine point-of-care circulating cathodic antigen assay for diagnosing Schistosomiasis mansoni infection in Brazil: A multicenter study
Registro en:
PIERI, Otavio Sarmento et al. Accuracy of the urine point-of-care circulating cathodic antigen assay for diagnosing Schistosomiasis mansoni infection in Brazil: A multicenter study. Revista da Sociedade Brasileira de Medicina Tropical, v. 55, e0238-2022, p. 1 - 5, 2022.
0037-8632
10.1590/0037-8682-0238-2-22
Autor
Pieri, Otavio Sarmento
Bezerra, Fernando Schemelzer Moraes
Coelho, Paulo Marcos Zech
Enk, Martin Johannes
Favre, Tereza Crisitna
Graeff-Teixeira, Carlos
Oliveira, Ricardo Riccio
Reis, Mitermayer Galvão dos
Andrade, Lee Senhorinha de Almeida
Beck, Lilian Christina Nóbrega Holsbach
Favero, Vivian
Fialho, Thainá Rodrigues de Souza
Guimarães, Ricardo José de Paula Souza e
Oliveira, Bruna Souza Santos
Pascoal, Vanessa Fey
Pinheiro, Marta Cristhiany Cunha
Santos, Ronald Alves dos
Silva, Luciano Kalabric
Siqueira, Isadora Cristina de
Souza, Renata Perotto de
Katz, Naftale
Resumen
Background: The World Health Organization recommends a market-ready, urine-based point-of-care diagnostic test for circulating
cathodic antigens (CCA) to determine the prevalence of S. mansoni. This study evaluated the performance of the URINE CCA (SCHISTO)
ECO TESTE® (POC-ECO), which is currently available in Brazil.
Methods: Residents from eight sites with different prevalence estimates provided one urine sample for POC-ECO and one stool sample
for Kato-Katz (KK) and Helmintex® (HTX) testing as an egg-detecting reference for infection status.
Results: None of the study sites had significantly higher POC-ECO accuracy than KK.
Conclusions: POC-ECO is not currently recommended in Brazilian schistosomiasis elimination programs.